KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Chemed (CHE) Equity Average (2016 - 2025)

Historic Equity Average for Chemed (CHE) over the last 17 years, with Q3 2025 value amounting to $1.1 billion.

  • Chemed's Equity Average fell 687.19% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year decrease of 687.19%. This contributed to the annual value of $1.1 billion for FY2024, which is 1679.85% up from last year.
  • According to the latest figures from Q3 2025, Chemed's Equity Average is $1.1 billion, which was down 687.19% from $1.2 billion recorded in Q2 2025.
  • In the past 5 years, Chemed's Equity Average registered a high of $1.2 billion during Q3 2024, and its lowest value of $645.0 million during Q1 2022.
  • For the 5-year period, Chemed's Equity Average averaged around $955.2 million, with its median value being $916.1 million (2023).
  • In the last 5 years, Chemed's Equity Average crashed by 2951.26% in 2022 and then surged by 4017.03% in 2023.
  • Chemed's Equity Average (Quarter) stood at $701.5 million in 2021, then increased by 8.35% to $760.1 million in 2022, then skyrocketed by 39.93% to $1.1 billion in 2023, then grew by 10.7% to $1.2 billion in 2024, then decreased by 3.38% to $1.1 billion in 2025.
  • Its Equity Average stands at $1.1 billion for Q3 2025, versus $1.2 billion for Q2 2025 and $1.2 billion for Q1 2025.